Synergy of cancer immunotherapy and radiotherapy.
作者信息
Mansfield Aaron S, Park Sean S, Dong Haidong
机构信息
Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Department of Radiation Oncology, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Aging (Albany NY). 2015 Mar;7(3):144-5. doi: 10.18632/aging.100730.
Abstract
摘要
相似文献
1
Synergy of cancer immunotherapy and radiotherapy.
Aging (Albany NY). 2015 Mar;7(3):144-5. doi: 10.18632/aging.100730.
2
Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy.
Clin Oncol (R Coll Radiol). 2015 Dec;27(12):696-9. doi: 10.1016/j.clon.2015.09.001. Epub 2015 Sep 26.
3
Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.
Prog Tumor Res. 2015;42:67-78. doi: 10.1159/000437185. Epub 2015 Sep 4.
4
Rationale for combining immunotherapy with chemotherapy.
Immunotherapy. 2015;7(3):309-16. doi: 10.2217/imt.14.111.
5
Immunotherapy and radiation.
Semin Oncol. 2014 Dec;41(6):702-13. doi: 10.1053/j.seminoncol.2014.09.019. Epub 2014 Oct 6.
6
Combination approaches to immunotherapy: the radiotherapy example.
Immunotherapy. 2009 Nov;1(6):1025-37. doi: 10.2217/imt.09.64.
7
[Mechanism of immunotherapy enhancement in cancer therapy by hyperthermia].
Gan To Kagaku Ryoho. 2009 Nov;36(12):1955-7.
8
Is classical stereotactic radiotherapy the optimal partner for immunotherapy?
Oncology (Williston Park). 2015 May;29(5):340, 347, 387.
9
Comparing equals when evaluating immunotherapy with different doses and fractions of radiation therapy.
Immunotherapy. 2015;7(8):847-9. doi: 10.2217/IMT.15.58. Epub 2015 Aug 13.
10
How Can Radiotherapy and Immunotherapy Combine for the Future of Cancer Care?
ONS Connect. 2016 Sep;31(8):15.
引用本文的文献
1
Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data.
Cancer Res Treat. 2024 Jul;56(3):785-794. doi: 10.4143/crt.2023.1014. Epub 2024 Jan 16.
2
Recent advances in the molecular targeted drugs for prostate cancer.
Int Urol Nephrol. 2023 Apr;55(4):777-789. doi: 10.1007/s11255-023-03487-3. Epub 2023 Jan 31.
3
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer.
Front Oncol. 2022 Oct 26;12:1022542. doi: 10.3389/fonc.2022.1022542. eCollection 2022.
4
Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy.
Front Bioeng Biotechnol. 2022 Sep 8;10:1010724. doi: 10.3389/fbioe.2022.1010724. eCollection 2022.
5
Prospective Immunophenotyping of CD8 T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT.
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):229-240. doi: 10.1016/j.ijrobp.2018.09.001. Epub 2018 Sep 8.
6
Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones.
Mol Ther. 2018 Jun 6;26(6):1414-1422. doi: 10.1016/j.ymthe.2018.04.001. Epub 2018 Apr 5.
7
Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes.
Mol Cancer Res. 2018 Aug;16(8):1209-1214. doi: 10.1158/1541-7786.MCR-17-0743. Epub 2018 Mar 28.
8
Current Immunotherapies for Sarcoma: Clinical Trials and Rationale.
Sarcoma. 2016;2016:9757219. doi: 10.1155/2016/9757219. Epub 2016 Sep 14.
本文引用的文献
1
PD-1 Restrains Radiotherapy-Induced Abscopal Effect.
Cancer Immunol Res. 2015 Jun;3(6):610-9. doi: 10.1158/2326-6066.CIR-14-0138. Epub 2015 Feb 19.
2
Immunotherapy and radiation therapy: considerations for successfully combining radiation into the paradigm of immuno-oncology drug development.
Radiat Res. 2014 Aug;182(2):252-7. doi: 10.1667/RR13707.1. Epub 2014 Jul 8.
3
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.
J Clin Invest. 2014 Feb;124(2):687-95. doi: 10.1172/JCI67313. Epub 2014 Jan 2.
4
Radiation and immunotherapy: a synergistic combination.
J Clin Invest. 2013 Jul;123(7):2756-63. doi: 10.1172/JCI69219. Epub 2013 Jul 1.
5
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):343-9. doi: 10.1016/j.ijrobp.2012.12.025. Epub 2013 Feb 22.
6
Immunologic correlates of the abscopal effect in a patient with melanoma.
N Engl J Med. 2012 Mar 8;366(10):925-31. doi: 10.1056/NEJMoa1112824.
Zotero 插件